Translational Development Acquisition Corp. - Ordinary Shares (TDAC)
10.74
+0.01 (0.09%)
NASDAQ· Last Trade: Jul 21st, 12:04 PM EDT
Detailed Quote
| Previous Close | 10.73 |
|---|---|
| Open | 10.72 |
| Bid | 10.73 |
| Ask | 10.74 |
| Day's Range | 10.72 - 10.74 |
| 52 Week Range | 10.32 - 10.80 |
| Volume | 3,462 |
| Market Cap | 55.20M |
| PE Ratio (TTM) | 0.4341 |
| EPS (TTM) | 24.7 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 15,612 |
Chart
News & Press Releases
TAIPEI, Taiwan and NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- ProLogium Holding Inc. (“ProLogium” or the “Company”), a global leader in the innovation and manufacturing of next-generation solid-state batteries, and Translational Development Acquisition Corp. ("TDAC") (Nasdaq: TDAC), a special purpose acquisition company, today announced they have entered into a definitive agreement for a business combination that would result in ProLogium becoming a publicly listed company (the “Transaction”).
By ProLogium Technology Co., Ltd. · Via GlobeNewswire · May 27, 2026